Approximately 20% of CRC patients will develop metastases, resulting in a less than 5-year survival rate of only 14% with conventional treatment (Rumpold et al., 2020)
Your provider adjusts the timeline based on your individual response and comfort level
doi:10.1186/s40001-024-02241-4 29
Patients come from across the GTA, Toronto, Mississauga, Brampton, Markham, Vaughan, Richmond Hill, Oakville, Burlington, with TTC access downtown and free parking for drivers
Maximus accepts both HSA and FSA cards for weight loss treatment
Tirzepatide isnt recommended during pregnancy because theres not enough human research to confirm its safe for a developing fetus